HR 8828 United States House · 117th Congress

FDA Ethics Act of 2022

Summary
FDA Ethics Act of 2022 This bill establishes several requirements for entities that contract with the Food and Drug Administration (FDA) relating to conflicts of interest, including requiring contractors to disclose conflicts of interest on an ongoing basis and prohibiting the FDA from hiring consultants who simultaneously provide services to drug manufacturers or other entities that are regulated by the FDA.
Bill status in committee 1 of 4 stages cleared
Introduction
Sep 2022
Committee Review
Floor Vote
President
Introduced Sep 14, 2022 Last action Sep 15, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Sep 15, 2022
House · Referred to committee
Referred to the Subcommittee on Health.
Sep 14, 2022
House · Referred to committee
Referred to the House Committee on Energy and Commerce.
Sep 14, 2022
House · Introduced
Introduced in House
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Ann M. Kuster
Ann M. Kuster
DDemocratic
NH
2